/* DAM 2022-07-18 removing shop menu EOF */
?>
Science Prostate cancer
The Prognostic Impact of Intraductal Carcinoma of the Prostate: A Systematic Review and Meta-Analysis
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: the OCUU-CRPC study
Promoting integrated care in prostate cancer through online prostate cancer-specific holistic needs assessment: a feasibility study in primary care
The diagnostic value of miRNA-141 in prostate cancer: A systematic review and PRISMA-compliant meta-analysis
Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis
Association between interleukin-8 rs4073 polymorphism and prostate cancer: A meta-analysis
Evaluation of Fall and Fracture Risk Among Men With Prostate Cancer Treated With Androgen Receptor Inhibitors: A Systematic Review and Meta-analysis
Association of the Placement of a Perirectal Hydrogel Spacer With the Clinical Outcomes of Men Receiving Radiotherapy for Prostate Cancer: A Systematic Review and Meta-analysis
The primary treatment of prostate cancer with high-intensity focused ultrasound: A systematic review and meta-analysis
Effects of exercise interventions on social and cognitive functioning of men with prostate cancer: a meta-analysis
The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis
The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis
PSMA-targeted Radiotracers versus 18 F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis
Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis
Association of gene polymorphisms of KLK3 and prostate cancer: A meta-analysis
Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis
Moderators of the effect of psychosocial interventions on fatigue in women with breast cancer and men with prostate cancer: Individual patient data meta-analyses
Association between Postoperative Detection of Circulating Tumor Cells and Recurrence in Patients with Prostate Cancer
Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
Prostate Cancer Nodal Staging: Using Deep Learning to Predict 68 Ga-PSMA-Positivity from CT Imaging Alone
The effect of information on prostate cancer screening decision process: a discrete choice experiment
Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials
HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer
Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study
Sequencing of Androgen-Deprivation Therapy With External-Beam Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled Trial
Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
Olaparib for Metastatic Castration-Resistant Prostate Cancer
Patients’ education level and treatment modality for prostate cancer in the Finnish Randomized Study of Screening for Prostate Cancer
Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy
The content provided on AGE2B website is intended for informational and educational purposes only. It should not be considered, nor should it replace, professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider for any questions you may have regarding a medical condition.